Alpha DNA Investment Management’s Analog Devices ADI Stock Holding History

Alpha DNA Investment Management’s Portfolio ADI Stock Details ADI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,470	Closed	-$4.56M	–	14
2024 Q4	$4.56M	Buy	21,470 +12,879	+150%	+$2.85M	1.74%	8
2024 Q3	$1.98M	Buy	8,591 +4,082	+91%	+$920K	0.74%	26
2024 Q2	$1.03M	Sell	4,509 -231	-5%	-$49.3K	0.4%	46
2024 Q1	$938K	Buy	+4,740	New	+$911K	0.35%	58
2023 Q2	–	Sell	-7,196	Closed	-$1.42M	–	149
2023 Q1	$1.42M	Sell	7,196 -18,218	-72%	-$3.27M	0.42%	44
2022 Q4	$4.17M	Buy	25,414 +4,971	+24%	+$776K	1.47%	4
2022 Q3	$2.85M	Buy	20,443 +12,191	+148%	+$1.93M	2.37%	3
2022 Q2	$1.21M	Sell	8,252 -344	-4%	-$54.2K	1.03%	12
2022 Q1	$1.42M	Buy	+8,596	New	+$1.39M	1%	21
2021 Q2	–	Sell	-120	Closed	-$18K	–	109
2021 Q1	$18K	Buy	+120	New	+$18.4K	0.02%	255

Other funds holding ADI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Alpha DNA Investment Management's ADI Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Analog Devices (ADI) in Q1 2025, closing a stake of 21,470 shares — an estimated $4.56M sold.

Alpha DNA Investment Management first reported a position in ADI in Q1 2021 and held it in 10 quarters. The position peaked at $4.56M in Q4 2024. 1,744 funds tracked by Wall St. Rank hold ADI as of Q1 2025.

Alpha DNA Investment Management reported no remaining Analog Devices position as of Q1 2025 after selling out during the quarter.
Alpha DNA Investment Management sold 21,470 Analog Devices shares in Q1 2025, an estimated $4.56M.
Alpha DNA Investment Management first reported a position in Analog Devices in Q1 2021 and held it in 10 quarters.
Alpha DNA Investment Management's Analog Devices position peaked at $4.56M in Q4 2024.
1,744 funds tracked by Wall St. Rank held Analog Devices as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.